Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination

By Uzzo R.G.   Pinover W.H.   Horwitz E.M.   Parlanti A.   Mazzoni S.   Raysor S.   Mirchandani I.   Greenberg R.E.   Pollack A.   Hanks G.E.   Watkins-Bruner D.  

Urology, Vol. 61, Iss. 4, 2003-04 ,pp. : 754-759

Elsevier

Access to resources Recommend Favorite

Validation of Epstein criteria of insignificant prostate cancer in Middle East patients

By Hekal Ihab   El-Tabey Nasr   Nabeeh Mohamed   El-Assmy Ahmed   El-Hameed Mohamed   Nabeeh Adel   Ibrahiem Elhousseiny  

International Urology and Nephrology, Vol. 42, Iss. 3, 2010-09 ,pp. : 667-671

Springer Publishing Company

Access to resources Recommend Favorite

Insignificant Prostate Cancer in Radical Prostatectomy Specimen: Time Trends and Preoperative Prediction

By Augustin H.   Hammerer P.G.   Graefen M.   Erbersdobler A.   Blonski J.   Palisaar J.   Daghofer F.   Huland H.  

European Urology, Vol. 43, Iss. 5, 2003-05 ,pp. : 455-460

Elsevier

Access to resources Recommend Favorite

pT0 after Radical Prostatectomy: Overtreatment for Insignificant Prostate Cancer?

By Hammerer P.  

European Urology, Vol. 45, Iss. 1, 2004-01 ,pp. : 35-35

Elsevier

Access to resources Recommend Favorite

Total PSA, free PSA/total PSA ratio, and molecular PSA detection in prostate cancer: which is clinically effective and when?

By Basso D.   Fogar P.   Piva M.G.   Navaglia F.   Mazza S.   Prayer-Galetti T.   Castellucci E.   Pagano F.   Plebani M.  

Urology, Vol. 55, Iss. 5, 2000-05 ,pp. : 710-715

Elsevier

Access to resources Recommend Favorite